These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9532327)

  • 1. [Multicenter open randomized trial of meropenem in comparison to ceftazidime and amikacin used in combination in severe hospital infections].
    Iakovlev SV; Iakovlev VP; Derevianko II; Kira EF;
    Antibiot Khimioter; 1998; 43(1):15-23. PubMed ID: 9532327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
    Mouton YJ; Beuscart C
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():145-56. PubMed ID: 8543490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin.
    Solberg CO; Sjursen H
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():157-66. PubMed ID: 8543491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of monotherapy by meropenem in ventilator-associated pneumonia].
    Alvarez Lerma F;
    Antibiot Khimioter; 2001; 46(12):42-52. PubMed ID: 12108093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy.
    Hung KC; Chiu HH; Tseng YC; Wang JH; Lin HC; Tsai FJ; Peng CT
    J Microbiol Immunol Infect; 2003 Dec; 36(4):254-9. PubMed ID: 14723254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group.
    Sieger B; Berman SJ; Geckler RW; Farkas SA
    Crit Care Med; 1997 Oct; 25(10):1663-70. PubMed ID: 9377880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
    Cometta A; Calandra T; Gaya H; Zinner SH; de Bock R; Del Favero A; Bucaneve G; Crokaert F; Kern WV; Klastersky J; Langenaeken I; Micozzi A; Padmos A; Paesmans M; Viscoli C; Glauser MP
    Antimicrob Agents Chemother; 1996 May; 40(5):1108-15. PubMed ID: 8723449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia.
    Alvarez Lerma F;
    J Chemother; 2001 Feb; 13(1):70-81. PubMed ID: 11233804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study.
    de la Cámara R; Figuera A; Sureda A; Hermida G; Verge G; Olalla I; Fernández Rañada JM; Domingo Albos A
    Haematologica; 1997; 82(6):668-75. PubMed ID: 9580087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections.
    Limson BM; Navarro-Almario E; Litam P; Que E; Kua LT
    Clin Ther; 1988; 10(5):589-93. PubMed ID: 2856601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey.
    Akova M; Akan H; Korten V; Biberoğlu K; Hayran M; Unal S; Kars A; Kansu E
    Int J Antimicrob Agents; 1999 Sep; 13(1):15-9. PubMed ID: 10563400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: a randomized, double-blind trial.
    Feld R; DePauw B; Berman S; Keating A; Ho W
    J Clin Oncol; 2000 Nov; 18(21):3690-8. PubMed ID: 11054442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program.
    Mazuski JE; Gasink LB; Armstrong J; Broadhurst H; Stone GG; Rank D; Llorens L; Newell P; Pachl J
    Clin Infect Dis; 2016 Jun; 62(11):1380-1389. PubMed ID: 26962078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.
    Qin X; Tran BG; Kim MJ; Wang L; Nguyen DA; Chen Q; Song J; Laud PJ; Stone GG; Chow JW
    Int J Antimicrob Agents; 2017 May; 49(5):579-588. PubMed ID: 28363526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of meropenem in the treatment of severe complicated urinary tract infections].
    Lopatkin NA; Derevianko II; Khodyreva LA; Kotliarova GA; Kondrat'eva EM; Lavrinova LN
    Antibiot Khimioter; 1999; 44(3):19-21. PubMed ID: 10382033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
    Beuscart C; Leroy O; Mouton Y; Pappo M; Drugeon H
    Pathol Biol (Paris); 1989 May; 37(5):496-9. PubMed ID: 2674875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.